Disease Prevention

Disease Prevention
  • A Mailed Vape Kit Helped Smokers Quit, Even Without Coaching Calls

    CATEGORY: DISEASE PREVENTION

    Most people who try to quit smoking never sit across from a counselor. A British trial of 1,170 smokers asked what happens if you skip that step entirely: mail people an e-cigarette starter kit and let them get on with it. Six months later, 11.3% of the kit-only group had verifiably quit, compared with 6.4% of smokers who received only encouraging emails from the NHS stop-smoking program. Adding five phone calls to the kit nearly doubled the quit rate again, to 21.1%.1

    Three Groups, Checked by Breath Test

    Everyone in the trial smoked daily and wanted to stop. A computer split them three ways at random: automated supportive emails for a month, an e-cigarette starter kit sent by mail with phone instructions and nothing more, or the same kit plus five short calls, one on quit day and then weekly for four weeks. Quitting wasn’t taken on anyone’s word. It meant staying off cigarettes for months and passing a carbon monoxide breath test, and anyone who couldn’t be reached was counted as still smoking. Britain’s National Institute for Health and Care Research paid for the study, which appeared this week in NEJM Evidence.

    The Gap Was Still There a Year Later

    At twelve months, 16.8% of the kit-plus-calls group remained verifiably quit, against 9% with the kit alone and 5.4% with emails alone. Picture 100 smokers in each group. A year on, about five of the email group have stopped, nine of the kit group, and seventeen of those who also got the calls. Most successful quitters were still vaping at the one-year mark. The researchers note that vaping isn’t risk-free, though it carries a small fraction of smoking’s dangers. One wrinkle says a lot about real life: among the email-group members who did quit, more than two-thirds had gone out and bought e-cigarettes on their own.

    What Earlier Trials Couldn’t Say

    A landmark 2019 trial found e-cigarettes nearly twice as effective as nicotine-replacement therapy, patches and gum, at 18% versus 9.9% quit at one year, but everyone in it got weekly counseling.2 That left open whether the vaping itself was doing the work, or vaping plus a professional at your elbow. This trial answers it in two directions at once. The kit helped on its own, and the counseling still roughly doubled its effect. Support helps when people can get it. The kit works even when they can’t.

    Key Takeaways

    • Support made the biggest single difference: an e-cigarette kit with five phone calls got 21.1% of smokers to a verified quit at six months, versus 11.3% for the kit alone.
    • The kit alone still beat encouraging emails, 11.3% to 6.4%, and the advantage held at a year.
    • Quitting was confirmed with breath tests, and dropouts were counted as smokers, so these rates aren’t inflated by wishful self-report.
    • Most people who quit were still using e-cigarettes a year in, a trade-off the researchers describe as far less risky than continuing to smoke.

    References

    1. Myers Smith K, Przulj D, Pesola F, et al. E-Cigarettes with and without Behavioral Support for Smoking Cessation. NEJM Evidence. 2026;5(11):EVIDoa2600065. link
    2. Hajek P, Phillips-Waller A, Przulj D, et al. A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy. New England Journal of Medicine. 2019;380(7):629–637. link

    More from Disease Prevention!


  • Young People Quit Vaping Far More Often on a Pill Long Used for Smoking

    Plenty of young people want to stop vaping and find they can't. In a Boston trial of 261 teens and young adults, a pill long prescribed to help smokers quit got 51% of them off nicotine vapes by the end… Read More →


  • Most Routine Blood Tests Barely Moved With or Without Fasting

    If you've ever sat in a lab's waiting room at 8 a.m., queasy and coffee-less, this one's for you. Researchers who combed through 9.7 million blood test results found that only 10 of 121 common tests meaningfully shifted with how… Read More →


  • Smokers Offered Cash Rewards Quit More Often Than Those Given Free Medication

    Money worked where free medicine didn't. In a trial of 3,220 adults who smoked daily and had been referred for a lung cancer screening scan, offering up to $600 in rewards for verified quitting roughly doubled the success rate: 8.8%… Read More →


  • Young Children’s Cavities Stopped Progressing More Often With a Brush-On Liquid

    A toddler with deep cavities usually faces the drill, and often sedation or even a trip to an operating room to tolerate it. A large randomized trial now shows a gentler option holds up: a liquid called silver diamine fluoride,… Read More →


  • Young Vapers on a Standard Quit-Smoking Pill Quit Far More Often

    Plenty of young people who vape nicotine have tried to stop and discovered how hard that is. In the first placebo-controlled medication trial aimed squarely at them, a familiar quit-smoking pill changed the odds dramatically: 51% of 16-to-25-year-olds taking varenicline… Read More →


  • Smokers Taking a Plant-Derived Pill Were Far More Likely to Quit and Stay Quit

    Anyone who's quit cigarettes and drifted back knows the arithmetic of willpower alone. A trial of 792 American smokers suggests the odds shift substantially with a pill called cytisinicline: 30.3% of those who took it for 12 weeks weren't smoking… Read More →


  • Men Given a Twice-Yearly Injection Were Protected From HIV

    An injection given just twice a year prevented nearly every expected HIV infection in an international trial of 3,265 people. Two participants receiving lenacapavir acquired HIV over the follow-up period, an infection rate 96% below what researchers calculated would have… Read More →


  • Very Hot Tea and Coffee Linked to Higher Risk of One Esophageal Cancer Type

    You know the sip. The tea has just been poured, it's clearly too hot, and you drink it anyway. Among nearly a million UK adults, the ones who said they liked their tea or coffee very hot went on to… Read More →


  • Silver Diamine Fluoride Halted More Cavities Than Placebo in Young Children

    A liquid brushed painlessly onto a cavity stopped the decay in 50.2% of treated baby teeth after eight months, against 17.4% of teeth that received a placebo, in a randomized trial of 830 young children. The liquid is silver diamine… Read More →